Choose your sales office

Product news

Filter

Open filter menu
Reset
Reset

ELITechGroup’s Vitamin D reagents; ready-to-use chemistry for efficiency

Vitamin D is a fat-soluble steroid hormone that is required for the intestinal absorption of calcium, maintenance of calcium homeostasis, and protection against osteomalacia i.e. softening of the bones. Vitamin D deficiency can lead to loss of bone density which can contribute to osteoporosis (reduction in bone mass) and fractures…
READ MORE

ELITechGroup’s Cholinesterase – an economical option for low-volume testing

The primary role of Cholinesterase in Clinical Diagnostics is to detect or monitor an acquired or inherited pseudocholinesterase deficiency. Pseudocholinesterase deficiency is a condition that causes increased sensitivity to certain muscle relaxant drugs used during general anesthesia (choline esters). These drugs relax the muscles used for movement, including those used…
READ MORE

IVDR compliance at ELITechGroup Clinical Chemistry

As a European-based (EU) manufacturer of IVD products, used in clinical diagnostic laboratories throughout the world, the introduction of the EU’s IVDR is of paramount importance for ELITechGroup’s Clinical Systems division. European Invitro Diagnostic Medical Device Regulations (IVDR) The IVDR will replace the existing In Vitro Diagnostic Medical Devices Directive…
READ MORE

ELITECHGROUP ACQUIRES GONOTEC, A LEADING MARKET PLAYER IN FREEZING POINT OSMOMETRY

  ELITechGroup, market leader in global vapor pressure osmometer technology, announces the acquisition of GONOTEC, a leading market player in freezing point osmometer technology. The purchase of the company unites two osmometry market leaders, providing the industry with a full range of osmometry solutions that meet specific needs enabling physicians…
READ MORE

NGSP Recertification of HbA1c methods for Selectra Pro M and Pro S

According to the 9th Edition of the IDF Diabetes Atlas 463 million adults (20-79 years) have Diabetes and based on current trends this number is expected to reach 700 million by 2045. ​It is estimated almost 232 million people have undiagnosed diabetes (2019). ​So, it is not surprising that Diabetes…
READ MORE

Hematology Industry Expected to Grow to $2.6B by 2020

The global hematology analyzers market is expected to grow to more than $2.6 billion by 2020, according to a recent study by technology advisory and research firm Technavio. The Technavio market report includes a detailed exploration of market trends and revenue for the industry and explores forecasts for different regions…
READ MORE